Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekert

Showing results (461-470 of 492) with videos related to

Pageof 50
Sort By:
Neurosurgery|September 9, 2025
Quality-of-Life Outcomes in Adults and Children With Chiari 1 Malformation and in Those Managed Without Surgery: A Prospective, Multicenter, Observational StudyRory J Piper, Fardad T Afshari, Wai C Soon, et al.
Blood Advances|June 23, 2020
Cotargeting BCL-2 and MCL-1 in high-risk B-ALLDonia M Moujalled, Diane T Hanna, Soroor Hediyeh-Zadeh, et al.
Nature Biomedical Engineering|December 27, 2023
Towards in vitro models for reducing or replacing the use of animals in drug testingDavid M Stresser, Anna K Kopec, Philip Hewitt, et al.
The Journal of Clinical Investigation|June 26, 2018
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastomaBehrouz Hassannia, Bartosz Wiernicki, Irina Ingold, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
ALTEX|January 22, 2022
Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)Szczepan W Baran, Paul C Brown, Andreas R Baudy, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.
Leukemia|March 23, 2019
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusionsClaus Meyer, Bruno A Lopes, Aurélie Caye-Eude, et al.
Cancer Discovery|May 16, 2023
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in LeukemiaWinnie L Kan, Urmi Dhagat, Kerstin B Kaufmann, et al.
Pageof 50

Showing results (461-470 of 492) with videos related to

Sort By:
Pageof 50
Neurosurgery|September 9, 2025
Quality-of-Life Outcomes in Adults and Children With Chiari 1 Malformation and in Those Managed Without Surgery: A Prospective, Multicenter, Observational StudyRory J Piper, Fardad T Afshari, Wai C Soon, et al.
Blood Advances|June 23, 2020
Cotargeting BCL-2 and MCL-1 in high-risk B-ALLDonia M Moujalled, Diane T Hanna, Soroor Hediyeh-Zadeh, et al.
Nature Biomedical Engineering|December 27, 2023
Towards in vitro models for reducing or replacing the use of animals in drug testingDavid M Stresser, Anna K Kopec, Philip Hewitt, et al.
The Journal of Clinical Investigation|June 26, 2018
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastomaBehrouz Hassannia, Bartosz Wiernicki, Irina Ingold, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
ALTEX|January 22, 2022
Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)Szczepan W Baran, Paul C Brown, Andreas R Baudy, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.
Leukemia|March 23, 2019
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusionsClaus Meyer, Bruno A Lopes, Aurélie Caye-Eude, et al.
Cancer Discovery|May 16, 2023
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in LeukemiaWinnie L Kan, Urmi Dhagat, Kerstin B Kaufmann, et al.
Pageof 50